Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

The Government announced the leucodepletion programme, which was implemented by the National Blood Service over time and completed by October 1999.

  • Read more about The Government announced the leucodepletion programme, which was implemented by the National Blood Service over time and completed by October 1999.

The United Kingdom Haemophilia Centre Directors' Organisation recommended recombinant Factor 8 for Haemophilia A.

  • Read more about The United Kingdom Haemophilia Centre Directors' Organisation recommended recombinant Factor 8 for Haemophilia A.

The National Blood Authority began working towards the possible extension of leucodepletion of blood.

  • Read more about The National Blood Authority began working towards the possible extension of leucodepletion of blood.

The National Blood Authority initiated a recall of plasma products after establishing that they contained contributions from a donor who subsequently developed vCJD.

  • Read more about The National Blood Authority initiated a recall of plasma products after establishing that they contained contributions from a donor who subsequently developed vCJD.

The Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation agreed that recipients of vCJD-implicated product should not be informed.

  • Read more about The Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation agreed that recipients of vCJD-implicated product should not be informed.

The Chief Medical Officer issued a statement reporting that three patients who had suffered from vCJD had been blood donors, and a fourth was suspected of having been one too.

  • Read more about The Chief Medical Officer issued a statement reporting that three patients who had suffered from vCJD had been blood donors, and a fourth was suspected of having been one too.

Blood transfusion services were required to ask about family history of CJD.

  • Read more about Blood transfusion services were required to ask about family history of CJD.

The probable link between BSE in cows and vCJD in humans was announced in Parliament.

  • Read more about The probable link between BSE in cows and vCJD in humans was announced in Parliament.

BSE was first formally identified as variant Creutzfeldt Jakob Disease ("vCJD") in humans.

  • Read more about BSE was first formally identified as variant Creutzfeldt Jakob Disease ("vCJD") in humans.

The first Bovine Spongiform Encephalopathy ("BSE", mad cow disease) case was confirmed.

  • Read more about The first Bovine Spongiform Encephalopathy ("BSE", mad cow disease) case was confirmed.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 782
  • Page 783
  • Page 784
  • Page 785
  • Current page 786
  • Page 787
  • Page 788
  • Page 789
  • Page 790
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.